Nanosphere Health Sciences Inc (NSHS.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
May 03, 16:00
Nanosphere Health Sciences Free Cash Flow (Quarterly): -0.0359M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0359M |
| June 30, 2023 | 0.0059M |
| March 31, 2023 | -0.0288M |
| December 31, 2022 | 0.0211M |
| September 30, 2022 | -0.0522M |
| June 30, 2022 | -0.0505M |
| March 31, 2022 | -0.0063M |
| December 31, 2021 | -0.0244M |
| September 30, 2021 | -0.0496M |
| June 30, 2021 | 0.0029M |
| March 31, 2021 | -0.0098M |
| December 31, 2020 | -0.0057M |
| September 30, 2020 | 0.0046M |
| June 30, 2020 | 0.0046M |
| March 31, 2020 | -0.0668M |
| December 31, 2019 | -0.1502M |
| September 30, 2019 | 0.2969M |
| June 30, 2019 | -0.7352M |
| March 31, 2019 | -0.9142M |
| December 31, 2018 | -0.865M |
| September 30, 2018 | -0.8635M |
| June 30, 2018 | -1.461M |
| March 31, 2018 | -1.40M |
| December 31, 2017 | -0.6484M |
| September 30, 2017 | -0.2199M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.3831M |
| March 31, 2017 | -0.3908M |
| December 31, 2016 | -0.1261M |
| September 30, 2016 | -0.1664M |
| June 30, 2016 | -0.0693M |
| March 31, 2016 | -0.0338M |
| December 31, 2015 | 0.0011M |
| September 30, 2015 | -0.0333M |
| June 30, 2015 | -0.0394M |
| March 31, 2015 | 0.0031M |
| December 31, 2014 | -0.0024M |
| September 30, 2014 | -0.4111M |
| June 30, 2014 | -0.0052M |
| March 31, 2014 | 0.0011M |
| December 31, 2013 | -0.10M |
| September 30, 2013 | -0.1599M |
| June 30, 2013 | -0.5707M |
| March 31, 2013 | -0.8755M |
| December 31, 2012 | -0.903M |
| September 30, 2012 | -0.8742M |
| June 30, 2012 | -1.252M |
| March 31, 2012 | -0.9431M |
| December 31, 2011 | -0.9846M |
| September 30, 2011 | -1.050M |
| June 30, 2011 | -3.390M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-0.7352M
Minimum
Jun 2019
0.2969M
Maximum
Sep 2019
-0.0489M
Average
-0.0171M
Median
Free Cash Flow (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0062M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Lobe Sciences Ltd | -0.0948M |
| Algernon Pharmaceuticals Inc | -- |